Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?
Autor: | Ash Monga, Annette Kuhn, M. D. Mueller, Stefan Mohr, Sara Imboden, Christine Marthaler |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Adult
medicine.medical_specialty Sling (implant) Visual analogue scale Urology Acrylic Resins 030232 urology & nephrology 610 Medicine & health Urinary incontinence 03 medical and health sciences 0302 clinical medicine medicine Humans Prospective cohort study Aged Aged 80 and over Mixed urinary incontinence 030219 obstetrics & reproductive medicine business.industry Obstetrics and Gynecology Hydrogels Middle Aged medicine.disease Treatment efficacy Safety profile Treatment Outcome Urinary Incontinence Overactive bladder Physical therapy Female medicine.symptom business |
Zdroj: | Mohr, Stefan; Marthaler-Benender, Christine; Imboden, Sara; Monga, Ash; Mueller, Michael; Kuhn, Annette (2017). Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome? International urogynecology journal, 28(11), pp. 1657-1661. Springer 10.1007/s00192-017-3332-5 |
DOI: | 10.7892/boris.110894 |
Popis: | INTRODUCTION AND HYPOTHESIS Mixed urinary incontinence (MUI), defined as mixed symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB), is a difficult entity if conservative treatment has failed. Cure rates are low compared with SUI, particularly the OAB component, may deteriorate after sling insertion. Bulking agents pose an appealing alternative for the treatment of MUI. They have shown beneficial effect in small case studies, but larger series are lacking. The aim of this prospective study was an analysis of treatment efficacy and safety profile of the bulking agent, Bulkamid, in female patients with MUI. METHODS One hundred fifty-four women with MUI symptoms (components of SUI/OAB within the limits of 60-40% either way) received bulking therapy with polyacrylamide hydrogel (Bulkamid). Patients were followed-up 3 months postoperatively. Primary outcome was the domain Incontinence impact on the King's Health Questionnaire (KHQ). Secondary outcomes were the other KHQ domains, visual analog scale (VAS), and International Continence Society (ICS) standardized pad weight test as objective measurement of incontinence. RESULTS Statistically significant improvements were found for all KHQ domains, pad weight test, and the visual analog scale (VAS) before and after bulking. Overall complication rate was 13%. CONCLUSIONS This study has shown improvement in MUI after bulking therapy according to both subjective and objective outcomes. We can advocate bulking therapy for treating MUI, as it is simple and safe and shows both objective and subjective improvement and relief. Long-term results (up to 1 year) are awaited. |
Databáze: | OpenAIRE |
Externí odkaz: |